Risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
At the request of the European Commission’s Directorate-General for Health and Consumers, a rapid risk assessment has been prepared concerning the outbreak of E Coli in Germany.
Outbreak of Shiga toxin-producing E. coli (STEC) in Germany, May 2011
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains capable of producing Shiga toxins, with the potential to cause severe enteric and systemic disease in humans.
Revised risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
An update of the initial rapid risk assessment on the outbreak of E. Coli in Germany, prepared at the request of the European Commission, first published on 27 May 2011.
Rapid risk assessment update: Outbreak of Shiga toxin-producing E. coli (STEC) O104:H4 2011 in the EU, 8 July 2011
This document is an update of the EFSA/ECDC joint rapid risk assessment of 29 June and aims to add new information to this and earlier initial rapid risk assessments (27 May and 14 June 2011).
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Outbreak of Legionnaires’ disease in a hotel in Calpe, Spain. December 2011 – January 2012
Following notification of a cluster of cases of Legionnaires’ disease, all associated with the same hotel in Spain, ECDC has prepared an assessment of the risk to the EU.
It concludes that as the hotel has been closed, the residual risk is limited to recent hotel visitors and staff, as well as staff still working in the hotel; particularly those involved in the implementation of control measures.